期刊文献+

隔离肢体灌注治疗局部进展期软组织肉瘤

下载PDF
导出
摘要 软组织肉瘤来源于脂肪、筋膜、肌肉、淋巴及血管等间叶组织的恶性肿瘤,可发生于任何部位,但约75%的病变位于四肢,最常见于大腿。这类肿瘤恶性程度高,尤其是局部进展期软组织肉瘤在就诊时通常体积较大,导致局部处理困难,需要广泛性手术或致残性手术(结合或不结合放疗)来进行治疗,术后可能导致严重的肢体功能障碍,其中大约10%的患者需要截肢。从以往的截肢手术到保肢手术,虽然一定程度上改善了患者的生存质量,
出处 《癌症进展》 2012年第5期481-486,共6页 Oncology Progress
  • 相关文献

参考文献26

  • 1Grunhagen DJ, de Wilt JH, Graveland WJ, et al. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and mel- phalan for limb-threatening soft tissue sarcoma [ J ]. Canc- er, 2006, 106 (8) : 1776 - 1784.
  • 2Bickels J, Manusama ER, Gutman M, et al. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity [ J ]. Eur J Surg Oncol, 1999, 25 (5) : 509 - 514.
  • 3Grunhagen D J, Brunstein F, Graveland W J, et al. Isolated limb perfusion with tumor necrosis factor and melphalan prevents amputation in patients with multiple sarcomas in arm or leg [J]. Ann Surg Oncol, 2005, 12 (6) : 473 - 479.
  • 4Grunhagen D J, de Wilt JH, Graveland WJ, et al. The pal- liative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and mel- anoma [J]. Cancer, 2006, 106 (1): 156-162.
  • 5Lans TE, Grunhagen D J, de Wilt JH, et al. Isolated limb perfusions with tumor necrosis factor and melphalan for lo- cally recurrent soft tissue sarcoma in previously irradiated limbs [ J ]. Ann Surg Oneol, 2005, 12 (5) : 406 - 411.
  • 6Grunhagen DJ, de Wilt JH, van Gell AN, et al. TNF dose reduction in isolated limb perfusion [ J ]. Eur J Surg On- col, 2005, 31 (9):1011-1019.
  • 7Hoven-Gondrie ML, Thijssens KM, Van den Dungen JJ, et al. Long-term loeoregional vascular morbidity after isolated limb perfusion and external-beam radiotherapy for soft tis- sue sarcoma of the extremity [ J]. Ann Surg Oncol, 2007, 14 (7):2105-2112.
  • 8van Ginkle RJ, Thijssens KM, Pras E, et al. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation [ J ]. Ann Surg Oncol, 2007, 14 (4): 1499 - 1506.
  • 9van Etten B, van Geel AN, de Wilt JH, et al. Fifty tumor necrosis factor-based isolated limb perfusions for limb sal- vage in patients older than 75 years with limb-threatening soft tissue sarcomas and other extremity tumors [ J ]. Ann Surg Oncol, 2003, 10 ( 1 ) : 32 - 37.
  • 10Lejeune FJ, Pujol N, Lienard D, et al. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melpha-lan for non-resectable soft tissue sarcoma of the extremities [ J ]. Eur J Surg Oncol, 2000, 26 (7) : 669 - 678.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部